Donor Lymphocytes to Prevent Graft-Versus-Host Disease in Patients With Chronic Myeloid Leukemia
Status:
Withdrawn
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
RATIONALE: Peripheral stem cell transplantation may be able to replace immune cells that were
destroyed by chemotherapy used to kill cancer cells. Sometimes the transplanted cells can be
rejected by the body's normal tissues. Donor lymphocytes that have been treated in the
laboratory may prevent this from happening.
PURPOSE: Randomized phase II trial to study the effectiveness of donor lymphocytes to prevent
graft-versus-host disease in patients who are undergoing peripheral stem cell transplantation
for chronic myeloid leukemia.